Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1987 1
1989 1
2000 1
2012 1
2015 1
2018 2
2019 1
2020 2
2021 2
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Dilated cardiomyopathy 1G"
Page 1
Changes in clinical and imaging variables during withdrawal of heart failure therapy in recovered dilated cardiomyopathy.
Halliday BP, Owen R, Gregson J, Vazir A, Wassall R, Khalique Z, Lota AS, Tayal U, Hammersley DJ, Jones RE, Pennell DJ, Cowie MR, Cleland JGF, Prasad SK. Halliday BP, et al. ESC Heart Fail. 2022 Jun;9(3):1616-1624. doi: 10.1002/ehf2.13872. Epub 2022 Mar 8. ESC Heart Fail. 2022. PMID: 35257498 Free PMC article.
AIMS: This study aimed to profile the changes in non-invasive clinical, biochemical, and imaging markers during withdrawal of therapy in patients with recovered dilated cardiomyopathy, providing insights into the pathophysiology of relapse. ...A rise in heart …
AIMS: This study aimed to profile the changes in non-invasive clinical, biochemical, and imaging markers during withdrawal of therapy …
Myocardial remodelling after withdrawing therapy for heart failure in patients with recovered dilated cardiomyopathy: insights from TRED-HF.
Halliday BP, Owen R, Gregson J, S Vassiliou V, Chen X, Wage R, Lota AS, Khalique Z, Tayal U, Hammersley DJ, Jones RE, Baksi AJ, Cowie MR, Cleland JGF, Pennell DJ, Prasad SK. Halliday BP, et al. Eur J Heart Fail. 2021 Feb;23(2):293-301. doi: 10.1002/ejhf.2063. Epub 2020 Dec 14. Eur J Heart Fail. 2021. PMID: 33225554 Free article. Clinical Trial.
AIMS: To characterize adverse ventricular remodelling after withdrawing therapy in recovered dilated cardiomyopathy (DCM). METHODS AND RESULTS: TRED-HF was a randomized controlled trial with a follow-on single-arm cross-over phase that examined the saf …
AIMS: To characterize adverse ventricular remodelling after withdrawing therapy in recovered dilated cardiomyopathy (DCM). MET …
Clinical Outcomes of Autologous Stem Cell-Patch Implantation for Patients With Heart Failure With Nonischemic Dilated Cardiomyopathy.
Domae K, Miyagawa S, Yoshikawa Y, Fukushima S, Hata H, Saito S, Kainuma S, Kashiyama N, Iseoka H, Ito E, Harada A, Takeda M, Sakata Y, Toda K, Pak K, Yamada T, Sawa Y. Domae K, et al. J Am Heart Assoc. 2021 Jul 6;10(13):e008649. doi: 10.1161/JAHA.117.008649. Epub 2021 Jul 2. J Am Heart Assoc. 2021. PMID: 34212772 Free PMC article. Clinical Trial.
Background Clinical effectiveness of autologous skeletal cell-patch implantation for nonischemic dilated cardiomyopathy has not been clearly elucidated in clinical settings. This clinical study aimed to determine the feasibility, safety, therape …
Background Clinical effectiveness of autologous skeletal cell-patch implantation for nonischemic dilated cardiomyopathy …
Comparison of Mesenchymal Stem Cell Efficacy in Ischemic Versus Nonischemic Dilated Cardiomyopathy.
Tompkins BA, Rieger AC, Florea V, Banerjee MN, Natsumeda M, Nigh ED, Landin AM, Rodriguez GM, Hatzistergos KE, Schulman IH, Hare JM. Tompkins BA, et al. J Am Heart Assoc. 2018 Jul 12;7(14):e008460. doi: 10.1161/JAHA.117.008460. J Am Heart Assoc. 2018. PMID: 30005555 Free PMC article.
BACKGROUND: Ischemic cardiomyopathy (ICM) and dilated cardiomyopathy (DCM) differ in histopathology and prognosis. ...METHODS AND RESULTS: We conducted a subanalysis of 3 single-center, randomized, and blinded clinical trials: (1) TAC-HFT (Trans …
BACKGROUND: Ischemic cardiomyopathy (ICM) and dilated cardiomyopathy (DCM) differ in histopathology and prognosis. ...M …
Intravenous immunoglobulin for presumed viral myocarditis in children and adults.
Robinson J, Hartling L, Vandermeer B, Klassen TP. Robinson J, et al. Cochrane Database Syst Rev. 2015 May 20;(5):CD004370. doi: 10.1002/14651858.CD004370.pub3. Cochrane Database Syst Rev. 2015. PMID: 25992494 Updated. Review.
The first relevant study involved 62 adults with recent-onset dilated cardiomyopathy randomly assigned to receive IVIG or an equivalent volume of 0.1% albumin in a blinded fashion. ...The only paediatric trial had high risk of bias but suggested that b …
The first relevant study involved 62 adults with recent-onset dilated cardiomyopathy randomly assigned to receive IVIG …
Intravenous immunoglobulin for presumed viral myocarditis in children and adults.
Robinson J, Hartling L, Vandermeer B, Sebastianski M, Klassen TP. Robinson J, et al. Cochrane Database Syst Rev. 2020 Aug 19;8(8):CD004370. doi: 10.1002/14651858.CD004370.pub4. Cochrane Database Syst Rev. 2020. PMID: 32835416 Free PMC article.
MAIN RESULTS: In this update we added two trials to the two previously included trials. A quasi-randomised trial was previously included due to a paucity of evidence from randomised trials; however, with the addition of two new randomised trials, it wa …
MAIN RESULTS: In this update we added two trials to the two previously included trials. A quasi-randomised trial was previousl …
Epicardial adipose tissue volume in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy: evaluation with cardiac magnetic resonance imaging.
Petrini M, Alì M, Cannaò PM, Zambelli D, Cozzi A, Codari M, Malavazos AE, Secchi F, Sardanelli F. Petrini M, et al. Clin Radiol. 2019 Jan;74(1):81.e1-81.e7. doi: 10.1016/j.crad.2018.09.006. Epub 2018 Oct 15. Clin Radiol. 2019. PMID: 30336943
AIM: To compare the amount of epicardial adipose tissue (EAT) in patients with coronary artery disease (CAD) or non-ischaemic dilated cardiomyopathy (NIDCM) with that in patients with negative cardiac magnetic resonance imaging (CMR). ...For each patient, the EAT ma …
AIM: To compare the amount of epicardial adipose tissue (EAT) in patients with coronary artery disease (CAD) or non-ischaemic dilated …
Use of myocardial scar characterization to predict ventricular arrhythmia in cardiac resynchronization therapy.
Fernández-Armenta J, Berruezo A, Mont L, Sitges M, Andreu D, Silva E, Ortiz-Pérez JT, Tolosana JM, de Caralt TM, Perea RJ, Calvo N, Trucco E, Borràs R, Matas M, Brugada J. Fernández-Armenta J, et al. Europace. 2012 Nov;14(11):1578-86. doi: 10.1093/europace/eus104. Epub 2012 May 4. Europace. 2012. PMID: 22562658
METHODS AND RESULTS: A cohort of 78 consecutive patients with dilated cardiomyopathy and class I indication for CRT-D were prospectively enrolled. ...In a multivariate Cox proportional hazards regression model for clinical and ce-CMR variables, the scar mass …
METHODS AND RESULTS: A cohort of 78 consecutive patients with dilated cardiomyopathy and class I indication for CRT-D were pro …
Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy.
Foley RN, Parfrey PS, Morgan J, Barré PE, Campbell P, Cartier P, Coyle D, Fine A, Handa P, Kingma I, Lau CY, Levin A, Mendelssohn D, Muirhead N, Murphy B, Plante RK, Posen G, Wells GA. Foley RN, et al. Kidney Int. 2000 Sep;58(3):1325-35. doi: 10.1046/j.1523-1755.2000.00289.x. Kidney Int. 2000. PMID: 10972697 Free article. Clinical Trial.
METHODS: One hundred forty-six hemodialysis patients with either concentric LV hypertrophy or LV dilation were randomly assigned to receive doses of epoetin alpha designed to achieve hemoglobin levels of 10 or 13.5 g/dL. ...
METHODS: One hundred forty-six hemodialysis patients with either concentric LV hypertrophy or LV dilation were randomly assigned to r …
Lethal cardiac toxicity after cisplatin and 5-fluorouracil chemotherapy. Report of a case with necropsy study.
Martin M, Diaz-Rubio E, Furió V, Blázquez J, Almenarez J, Fariña J. Martin M, et al. Am J Clin Oncol. 1989 Jun;12(3):229-34. doi: 10.1097/00000421-198906000-00010. Am J Clin Oncol. 1989. PMID: 2729179
This article presents a patient affected with epidermoid carcinoma of the soft palate who developed a dilated myocardiopathy with aortic embolism and fatal left cardiac failure after treatment with cisplatin (100 mg/m2, day 1) and 5-fluorouracil (1 g/m2/day i.v. days 2-6). …
This article presents a patient affected with epidermoid carcinoma of the soft palate who developed a dilated myocardiopathy with aor …
12 results